[Use of propofol as an anesthetic agent in a pediatric patient with Steinert's myotonic dystrophy].
Cano
J M
JM
Mulas
D
D
Sorribes
V
V
Lorente
L
L
Roldán
J
J
Mas
J
J
D018686:Anesthetics, Intravenous; D002318:Cardiovascular Diseases / Q000517:prevention & control; D000075202:Contraindications; D005260:Female; D006801:Humans; D006846:Hydrocarbons, Halogenated; D006849:Hydrocephalus / Q000150:complications / Q000601:surgery; D007223:Infant; D007431:Intraoperative Complications / Q000517:prevention & control; D008305:Malignant Hyperthermia / Q000517:prevention & control; D009223:Myotonic Dystrophy / Q000150:complications / Q000503:physiopathology; D009467:Neuromuscular Depolarizing Agents; D015742:Propofol; D012132:Respiratory Muscles / Q000503:physiopathology; D017287:Ventriculoperitoneal Shunt
D018686:Anesthetics, Intravenous; D006846:Hydrocarbons, Halogenated; D009467:Neuromuscular Depolarizing Agents; D015742:Propofol
Utilización del propofol como agente anestésico en un paciente pediátrico afectado de distrofia miotónica de Steinert.